cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

David N. Louis(Harvard University), Pieter Wesseling(Princess Máxima Center), Kenneth Aldape(National Cancer Institute), Daniel J. Brat(Northwestern University), David Capper(German Cancer Research Center), Ian A. Cree(Centre international de recherche sur le cancer), Charles G. Eberhart(Johns Hopkins University), Dominique Figarella‐Branger(Centre National de la Recherche Scientifique), Maryam Fouladi(Cincinnati Children's Hospital Medical Center), Gregory N. Fuller(The University of Texas MD Anderson Cancer Center), Caterina Giannini(Mayo Clinic), Christine Haberler(Medical University of Vienna), Cynthia Hawkins(University of Toronto), Takashi Komori(Tokyo Metropolitan Neurological Hospital), Johan M. Kros(Erasmus MC), Ho‐Keung Ng(Chinese University of Hong Kong), Brent A. Orr(St. Jude Children's Research Hospital), Sung‐Hye Park(Seoul National University), Werner Paulus(University Hospital Münster), Arie Perry(University of California, San Francisco), Torsten Pietsch(University of Bonn), Guido Reifenberger(Deutschen Konsortium für Translationale Krebsforschung), Marc Rosenblum(Memorial Sloan Kettering Cancer Center), Brian Rous(Cambridge University Hospitals NHS Foundation Trust), Felix Sahm(German Cancer Research Center), Chitra Sarkar(All India Institute of Medical Sciences), David A. Solomon(University of California, San Francisco), Uri Tabori(University of Toronto), Martin J. van den Bent(Erasmus MC Cancer Institute), Andreas von Deimling(German Cancer Research Center), Michael Weller(University of Zurich), Valerie A. White(Centre international de recherche sur le cancer), David W. Ellison(St. Jude Children's Research Hospital)
Brain Pathology
April 19, 2020
Cited by 532Open Access
Full Text

Abstract

cIMPACT-NOW (the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy) was established to evaluate and make practical recommendations on recent advances in the field of CNS tumor classification, particularly in light of the rapid progress in molecular insights into these neoplasms. For Round 2 of its deliberations, cIMPACT-NOW Working Committee 3 was reconstituted and convened in Utrecht, The Netherlands, for a meeting designed to review putative new CNS tumor types in advance of any future World Health Organization meeting on CNS tumor classification. In preparatory activities for the meeting and at the actual meeting, a list of possible entities was assembled and each type and subtype debated. Working Committee 3 recommended that a substantial number of newly recognized types and subtypes should be considered for inclusion in future CNS tumor classifications. In addition, the group endorsed a number of principles-relating to classification categories, approaches to classification, nomenclature, and grading-that the group hopes will also inform the future classification of CNS neoplasms.


Related Papers

No related papers found

Powered by citation graph analysis